Earlier this year, public health authorities in the U.S. and Europe alerted the public to the global proliferation of Monkeypox, a long-neglected disease that until this year was primarily limited to the areas of Western and Central Africa where the virus is endemic. However, as of Sept. 20, 2022, 104 countries have reported more than 62,000 cases, according to the U.S. Centers for Disease Control and Prevention. The disease has also been declared a Public Health Emergency in the U.S., which leads the world in total confirmed cases with more than 23,000.
Given these developments, U.S. clinical labs should prepare to offer a testing solution to patients who may have been infected with Monkeypox. During this webinar, our Lab Management Team will review the FDA's guidance for validating Monkeypox testing and provide a step-by-step overview of how to validate testing in your lab.
Healthcare is broken and I would like to be a part of fixing it. I believe that the medical laboratory industry needs to be disrupted, and I spend each day advocating for the value of clinical laboratories and seeking new and more efficient ways...
We provide comprehensive solutions to challenges facing the clinical laboratory community through Lab Management, Recruiting, Consulting, LIS, and Lab Director Services. Our mission is to make Quality Laboratory Testing More Accessible.